• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS27
Device Problem Device Dislodged or Dislocated (2923)
Patient Problems Hemoptysis (1887); Aortic Dissection (2491)
Event Date 09/13/2016
Event Type  Injury  
Manufacturer Narrative
Not yet received.
 
Event Description
The manufacturer was notified on 27-sept-2016 of the following: a perceval valve was successfully implanted in the patient during an avr.The echo showed the valve to be in good working order with no pvl.The patient then began choking up blood while intubated post op in the icu.The surgeon was present and immediately reoperated the patient.An aortic rupture was identified.The perceval had migrated and possibly tore the aorta.Perceval was explanted and an edwards magna ease was implanted.The patient is obese and has a very fragile aortic wall.
 
Manufacturer Narrative
Device was received nov 8, 2016 for analysis.Gross exam was completed nov 10, 2016.Design history record review was completed mar 1, 2017.The complete manufacturing and material records for the perceval s heart valve, model icv1211, s/n (b)(4), were pulled and reviewed by quality control at livanova (b)(4).The results confirmed that this valve satisfied all material, visual, and performance standards required for a perceval s heart valve at the time of manufacture and release.Visual inspection apr 5, 2017: according to the procedure (current revision at the time of manufacture and release), no non conformities were observed.The x-ray analysis ((b)(6) 2017) didn't show irregularities.No irregularity was identified with the p-np gauge test ((b)(4) 2017).No particular not conformities were observed.
 
Manufacturer Narrative
The visual inspection performed on the returned prosthesis confirmed the absence of manufacturing defects.No rupture of the stent was highlighted with the x-ray analysis and no irregularity was identified.Based on the performed analysis the reported event cannot be explained by any factor intrinsic in the involved device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
4125650
MDR Report Key6065116
MDR Text Key58699600
Report Number3004478276-2016-00129
Device Sequence Number1
Product Code DYE
UDI-Device Identifier00896208000443
UDI-Public(01)00896208000443(240)ICV1211(17)180929
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 06/23/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/28/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/29/2018
Device Model NumberPVS27
Device Catalogue NumberICV1211
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/08/2016
Is the Reporter a Health Professional? No
Date Manufacturer Received06/23/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/29/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-